Home › Funds › Kynam Capital Management, LP › BEAM
Kynam Capital Management, LP position in BEAM
BEAM THERAPEUTICS INC · Health Care
Kynam Capital Management, LP reported holding 3,933,894 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$96.2M, representing 5.33% of its reported portfolio and ranking #10 among its reported holdings. Kynam Capital Management, LP has disclosed BEAM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Kynam Capital Management, LP's BEAM position evolved
Kynam Capital Management, LP first disclosed a stake in BEAM in Q3 2024 at 1,302,085 shares (US$31.9M). The position peaked in Q2 2026 at 2,840,792 shares, worth US$97.5M. Across 9 filings, Kynam Capital Management, LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,933,894 shares valued at US$96.2M — an increase of 1,093,102 shares quarter over quarter.. Notable position changes include a 43% increase in Q1 2025 (shares fell 12% over the following quarter), a 63% trim in Q4 2025 (shares fell 15% over the following quarter), a 293% increase in Q1 2026 (shares rose 51% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.30M | $31.90M | New |
| Q4 2024 | 1.76M | $43.55M | Add |
| Q1 2025 | 2.52M | $49.18M | Add |
| Q2 2025 | 2.42M | $41.12M | Reduce |
| Q3 2025 | 2.52M | $61.10M | Add |
| Q4 2025 | 937.00K | $25.97M | Reduce |
| Q1 2026 | 3.68M | $87.75M | Add |
| Q2 2026 | 2.84M | $97.50M | Reduce |
| Q3 2026 | 3.93M | $96.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), ARK Invest (US$288.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$251.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 11.81M sh · $288.64M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.28M sh · $251.26M · Q3 2026
- ARCH Venture Management, LLC 4.54M sh · $155.77M · Q2 2026
- Amova Asset Management Americas, Inc. 3.35M sh · $81.76M · Q3 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Redmile Group, LLC 1.16M sh · $39.96M · Q2 2026
More on Kynam Capital Management, LP
FAQ
How long has Kynam Capital Management, LP held BEAM?
Kynam Capital Management, LP has disclosed BEAM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Kynam Capital Management, LP's current position in BEAM?
As of Q3 2026, Kynam Capital Management, LP holds 3.93M shares of BEAM (BEAM THERAPEUTICS INC), valued at $96.18M, representing 5.33% of its reported portfolio and ranking #10.
Has Kynam Capital Management, LP been buying or selling BEAM?
In the latest 13F filing (Q3 2026), Kynam Capital Management, LP increased its position in BEAM. The position peaked in Q2 2026 at 2.84M shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include Farallon Capital Management, ARK Invest, FARALLON CAPITAL MANAGEMENT, L.L.C., among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.